The Walt Disney Company (WDP)
XETRA Stock Exchange · Germany · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 100.50 |
|---|---|
| 52-week range | 80.20 – 101.00 |
| Return, 1 month / 3 months | +10.8% / +18.7% |
| Return, 1 year / 3 years | +4.0% / +33.3% |
| Trend | Uptrend |
| RSI (14) | 69 |
| Volatility (1 year) | 26.2% |
| Worst drawdown (1 year) | -18.5% |
| Average daily value traded | 0.18M EUR |
| Dividend yield | 1.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
The Walt Disney Company is an entertainment company based in the United States. It produces films and television programmes through studios including Walt Disney Pictures, Pixar, Marvel and Lucasfilm, and it operates theme parks and resorts in several countries. The company also runs television networks and streaming services, and it licenses its characters and brands for consumer products. Its customers include families, cinema audiences, park visitors, advertisers and subscribers to its streaming platforms.
The shares are listed on the XETRA Stock Exchange in Germany under the code WDP, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
The Walt Disney Company (WDP) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 100.50 on 22 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 140 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 4.0% and over the last three months it rose 18.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 83 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 13.0% | ||
| From 52-week high | 0.0% | ||
| Momentum | 69 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 18.7% | ||
| 6-month return | 13.3% | ||
| 12-month return, skipping the last month | -6.1% | ||
| Stability (higher is calmer) | 80 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 26.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.5% | ||
| Liquidity | 52 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.18M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 19 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.2% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.3% |
|---|---|
| 1 month | +10.8% |
| 3 months | +18.7% |
| 6 months | +13.3% |
| 1 year | +4.0% |
| 3 years | +33.3% |
| 5 years | −28.3% |
Signals
| 50-day / 200-day average | 93.35 / 88.96 |
|---|---|
| Golden / death cross (60 days) | Golden, 26 days ago |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.57 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Jun 2026 | USD 0.6671 |
| 15 Dec 2025 | USD 0.6671 |
| 24 Jun 2025 | USD 0.4448 |
| 16 Dec 2024 | USD 0.4448 |
| 8 Jul 2024 | USD 0.4003 |
| 5 Jul 2024 | USD 0.4500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.